BioSpace News Archive

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces its partnership with EVERSANA Life Sciences LLC as its launch and commercialisation partner to access the United States market for the GENinCode portfolio of polygenic cardiovascular disease products focused on genetic risk.

Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotech, announced that it is developing multiple next-generation cell and gene therapy platforms to cure difficult-to-treat cancers.

Targovax ASA, a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, has released two video presentations related to the ONCOS-102 mesothelioma 24-month data.

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization of mammalian, microbial and gene therapy biologics, announces the next webinar of its 2021 series: pDNA Manufacturing: An Optimized Platform Process.

Vibrating mesh nebulizers of various types have gained popularity in adult and pediatric patient populations as an advanced aerosol delivery device for respiratory therapy.

The drive for single blood drop analysis technologies stems from the need for inexpensive diagnostics for various disease treatment in the healthcare systems across the globe.

The development of modern treatment options have proved as extensive growth avenues for several markets. The global orthopedic bone cement market is one among them.

Oxygen concentrators are gaining traction in oxygen therapies, alongside oxygen cylinders and LMO.

Knee pain is common among all age groups and is associated with the bone structure of knee. Certain injuries or extension of a chronic medical condition result in knee pain.

The demand within the global market for hemodialysis vascular graft has been rising on account of the rising incidence of kidney diseases.